In an interview with Harvard Law Today, Carmel Shachar, executive director of the Petrie-Flom Center for Health Policy, Biotechnology, and Bioethics at Harvard Law School, says that political interference in the FDA’s process for ensuring that a vaccine is both safe and effective “opens the door to a public health disaster.”
From human rights in a time of populism to a comparative look at capital punishment to a focus on disability, healthcare and bioethics
COVID-19 presents a unique threat to people in prisons and jails, agreed panelists at “Incarcerated Populations and COVID-19: Public Health, Ethical, and Legal Concerns,” a webinar hosted by Harvard Law School’s Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics.
Student fellows at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics recently celebrated their fellowships’ end virtually when their capstone meeting moved to Zoom due to the COVID-19 pandemic.
At a March 27 Petrie-Flom event on medical debt and universal health coverage, health experts and journalists raise serious concerns about the affordability of testing and hospital care.
In a Q&A, scholars at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School raise important legal and ethical questions about health care delivery and the enactment of extraordinary public health measures in response to the ongoing epidemic.
The General Counsels Roundtable helps influential health law attorneys stay on top of or even ahead of changes in health law and policy. The roundtable connects GC to experts at HLS and the broader university, while also strengthening ties between faculty and legal practice.
Last week, Harvard commemorated the centennial of the 1918 influenza pandemic that killed more than 50 million people worldwide with Outbreak Week, a series of events across the university.